NVDA
NVIDIA Corporation
NVDA has the edge over SMRT overall, supported by stronger valuation and stronger modeled upside.
SMRT
SmartRent, Inc.
SMRT's outlook is improving, though it still trails on the overall score.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
SMRT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Stable | |
| Unavailable |
SMRT's revenue is currently healthy, and its cash flow is stable, but its profitability is under pressure. There isn't enough data to rate its balance sheet.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
SMRT PE Valuation
SMRT has no meaningful PE right now: it lost money over the past year.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
SMRT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
SMRT has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over SMRT on earnings quality, reporting a profit while its opponent remains loss making.
SMRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.09 | +$0.27 |
| Q2 2026 | -$0.10 | +$0.28 |
| Q1 2026 | -$0.13 | +$0.21 |
| Q4 2025 | -$0.32 | -$0.15 |
| Q3 2025 | -$0.36 | -$0.24 |
| Q2 2025 | -$0.38 | -$0.27 |
| Q1 2025 | -$0.34 | -$0.20 |
| Q4 2024 | -$0.17 | $0.00 |
SMRT is still losing money, but far less than before: $0.09 per share over the past year, against $0.49 at its worst in late 2022.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over SMRT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over SMRT on profitability, with a higher operating margin.
SMRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $41.6M | +15% |
| Q2 2026 | $39.8M | +4% |
| Q1 2026 | $38.7M | -6.4% |
| Q4 2025 | $36.5M | +3.1% |
| Q3 2025 | $36.2M | -11% |
| Q2 2025 | $38.3M | -21% |
| Q1 2025 | $41.3M | -18% |
| Q4 2024 | $35.4M | -41% |
SMRT's revenue is recovering but still below its 2023 peak: $42M last quarter, up 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -12% | +7.8 points |
| Q2 2026 | -16% | +14 points |
| Q1 2026 | -13% | +87 points |
| Q4 2025 | -11% | +26 points |
| Q3 2025 | -19% | +9.6 points |
| Q2 2025 | -31% | -16 points |
| Q1 2025 | -100% | -80 points |
| Q4 2024 | -37% | -27 points |
SMRT's operating margin was −12% last quarter, up 7.8 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over SMRT on cash flow, with more consistent year-over-year improvement.
SMRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.6M | +$4.9M |
| Q2 2026 | -$1.9M | +$14.3M |
| Q1 2026 | -$4.6M | +$9.8M |
| Q4 2025 | $7.7M | +$20.9M |
| Q3 2025 | -$2.2M | +$1.7M |
| Q2 2025 | -$16.2M | -$2.1M |
| Q1 2025 | -$14.3M | -$11M |
| Q4 2024 | -$13.3M | -281% |
SMRT's free cash flow has turned positive after five years mostly in the red: $4M over the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over SMRT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
SMRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -1.5M shares |
| 1 year | +1.4% | +2.5M shares |
| 3 years | -5.3% | -10.7M shares |
SMRT has 191M diluted shares, up 1.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4M |
| Q4 2025 | $29,000 |
| Q3 2025 | — |
| Q2 2025 | $3.7M |
| Q1 2025 | $1.2M |
| Q4 2024 | $5.1M |
| Q3 2024 | $17.1M |
| Q2 2024 | $2M |
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
SMRT Net Leverage
SMRT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
SMRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.8 | Neutral |
| Stochastic | 82.2 | Overbought |
SMRT's weekly RSI is 65 (neutral) and its Stochastic is 82 (overbought).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
SMRT PE vs Technology Sector
SMRT has no meaningful PE right now: it lost money over the past year.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
SMRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.32 | 27% above |
| 20 week MA | $1.25 | 34% above |
| 50 week MA | $1.44 | 16% above |
| 100 week MA | $1.34 | 25% above |
| 200 week MA | $1.99 | 16% below |
SMRT has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over SMRT on returns for 2026, with the stronger performance.
SMRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $11.1 | $10.1 | -9% |
| 2022 | $10.1 | $2.14 | -79% |
| 2023 | $2.14 | $3.19 | +49% |
| 2024 | $3.19 | $1.63 | -49% |
| 2025 | $1.63 | $2.03 | +25% |
| 2026 YTD | $2.03 | $1.67 | -18% |
SMRT has finished lower in three of the last five years. It's down 18% so far in 2026.